Antiviral Drugs - Benelux | Statista Market Forecast

In the Benelux region, the Antiviral Drugs market is expected to witness significant growth in the coming years.
By 2024, the projected revenue for this market is estimated to reach US$473.30m.
This growth is further expected to continue at a steady pace, with an annual growth rate of 1.43% (CAGR 2024-2029).
By 2029, the market volume in the Benelux region is projected to reach US$508.00m.
However, when comparing the global market, it is important to note that United States is anticipated to generate the highest revenue in this sector.
In 2024 alone, the projected revenue for Antiviral Drugs market United States is estimated to be around US$30.64bn.
This highlights the significant market potential and growth opportunities United States.
Benelux has seen a surge in demand for antiviral drugs due to the high prevalence of viral infections in the region.

Definition:
The Antiviral Drugs market includes treatments against viruses and virus-induced conditions, such as human immunodeficiency viruses (HIV), hepatitis B and C viruses (HBV and HCV), and Ebola. Therapies for the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are also included. HIV therapies also encompass highly active antiretroviral therapies (HAART) and post-exposure prophylaxis. In contrast to antibiotics, antivirals do not destroy the virus but rather inhibit its development.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, AbbVie, Merck

HIV
Hepatitis B and hepatitis C
Ebola
COVID-19

Vaccines
Antibiotics
Immunosuppressants
In vitro diagnostics and rapid tests

The Antiviral Drugs market in Benelux has been experiencing steady growth in recent years.

Customer preferences: Customers in the Benelux region have shown a growing demand for antiviral drugs due to the increasing prevalence of viral infections. This includes both prescription and over-the-counter drugs, with a preference for those that are effective against a wide range of viruses.

Trends in the market: One of the major trends in the Antiviral Drugs market in Benelux is the increasing focus on research and development of new drugs. This is driven by the need for more effective treatments for viral infections, as well as the potential for significant profits for pharmaceutical companies that are able to develop successful drugs. Another trend is the growing popularity of natural antiviral remedies, which are seen as a safer and more sustainable alternative to traditional drugs.

Local special circumstances: The Benelux region has a highly developed healthcare system, which has contributed to the growth of the Antiviral Drugs market. The region also has a large aging population, who are particularly vulnerable to viral infections and therefore have a high demand for antiviral drugs. Additionally, the region has a strong pharmaceutical industry, which has helped to drive innovation and research in the Antiviral Drugs market.

Underlying macroeconomic factors: The growth of the Antiviral Drugs market in Benelux is also influenced by broader macroeconomic factors. For example, rising healthcare costs and increasing government investment in healthcare have contributed to the growth of the market. Additionally, the region's strong economy and high standards of living have made it an attractive market for pharmaceutical companies looking to expand their operations.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.